Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2012
12/19/2012CN102178678B Application of lycorine in preparing medicament for treating diseases caused by human enterovirus 71 type infection
12/19/2012CN102174518B Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application
12/19/2012CN102154206B Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell
12/19/2012CN102138980B Medicament for treating hydrophobia and postpartum tetanus and preparation method thereof
12/19/2012CN102138965B Halenia elliptica D.Don extract and preparation method, pharmaceutical composition and application thereof
12/19/2012CN102021175B Optimized grass carp alpha interferon encoding gene and application thereof
12/19/2012CN101914106B Cefamandole nafate hydrate and preparation method thereof
12/19/2012CN101905021B Trigeminal live vaccine of canine distemper viruses, canine parvoviruses and Type I canine adenoviruses and preparation method thereof
12/19/2012CN101885676B Reduced anthraquinone compound with antibacterial activity
12/19/2012CN101787063B Anti-infective medicament and preparation and application thereof
12/19/2012CN101780150B Plant extract and pharmaceutical composition for treating cough and preparation method thereof
12/19/2012CN101606913B Cefixime dispersing tablet and preparation methods thereof
12/19/2012CN101549101B Traditional Chinese medicine for treating pneumoconiosis and drug-tolerant pulmonary tuberculosis and preparation method thereof
12/19/2012CN101496789B Sitafloxacin sustained-release pellet and preparation method thereof
12/19/2012CN101443330B Heterocycle non-nucleosides compound and preparation method thereof, medicament composition and purpose as antivirus antivirus inhibitor
12/19/2012CN101412740B Hydrate of azithromycin, and preparation and use thereof
12/18/2012US8334248 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
12/18/2012US8334102 Human CD28 specific monoclonal antibodies for antigen-nonspecific activation of T-lymphocytes
12/18/2012US8333987 Nourexin-4 nano-lipid emulsions
12/18/2012US8333983 Drug delivery system
12/18/2012US8333980 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
12/18/2012US8333976 Processes for inhibiting development of allergic disease
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/18/2012US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2554049C Quinoline derivatives for use as mycobacterial inhibitors
12/18/2012CA2504385C Thiadiazine compounds and uses thereof
12/18/2012CA2460692C Pesticidal formulations
12/18/2012CA2436057C A method for identification, isolation and production of antigens to a specific pathogen
12/18/2012CA2375269C A method of prophylaxis and treatment and agents useful for same
12/15/2012CA2834497A1 New hexahydropyrroloimidazolone compounds
12/15/2012CA2766417A1 Stabilized therapeutic small helical antiviral peptides
12/13/2012WO2012170792A1 Atazanavir metabolite derivatives
12/13/2012WO2012170524A1 Use of modified vasoactive intestinal peptides in the treatment of hypertension
12/13/2012WO2012170098A2 Arbovirus inhibitors and uses thereof
12/13/2012WO2012168733A1 Substituted 8 - amino - imidazo [1, 2-a] pyrazines as antibacterial agents
12/13/2012WO2012168468A1 Spray-dried lactobacillus stems / cells and the use of same against helicobacter pylori
12/13/2012WO2012168462A1 Antiinfective composition
12/13/2012WO2012168348A1 Method of treating dengue fever
12/13/2012WO2012168050A1 Use of epsilon-poly-l-lysine for increasing the bioavailability of antimicrobial peptides in the human skin
12/13/2012WO2012167656A1 Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof
12/13/2012WO2012167368A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
12/13/2012WO2012143608A3 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
12/13/2012WO2012143141A3 Antiviral compositions directed against the influenza virus nucleoprotein
12/13/2012WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof
12/13/2012US20120316344 Benzimidazole compound crystal
12/13/2012US20120316229 Oral antimicrobial pharmaceutical compositions
12/13/2012US20120316228 Oral antimicrobial pharmaceutical compositions
12/13/2012US20120316227 Chrysophaentin antimicrobial compounds that inhibit ftsz protein
12/13/2012US20120316223 MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE
12/13/2012US20120316222 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION
12/13/2012US20120316220 Methods and compositions for treating insects
12/13/2012US20120316208 Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316161 Novel antiviral compounds
12/13/2012US20120316158 Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316144 Antifungal agent
12/13/2012US20120316134 Anaesthetic composition
12/13/2012US20120316126 Compounds for the Treatment of Hepatitis C
12/13/2012US20120316125 Aminoglycosides: synthesis and use as antifungals
12/13/2012US20120316110 Injectable Cross-Linked Polymeric Preparations and Uses Thereof
12/13/2012US20120316106 Synergistic antibiotic combinations and derivatives
12/13/2012US20120316105 Polymyxin Derivates Useful As Antibacterial Agents
12/13/2012US20120316104 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
12/13/2012US20120316103 Cyclic antimicrobial peptides
12/13/2012US20120316102 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
12/13/2012US20120315343 Synchronized water and production and use thereof
12/13/2012US20120315341 Method for treating an inflammation or lesion caused by a virus
12/13/2012US20120315340 Post-Charging Of Zeolite Doped Plastics With Antimicrobial Metal Ions
12/13/2012US20120315326 Multiparticulate l-carnitine compositions and related methods
12/13/2012US20120315323 Influenza hemagglutinin antibodies, compositions and related methods
12/13/2012US20120315320 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
12/13/2012US20120315311 Antiviral composition and method of use
12/13/2012US20120315306 Pharmaceutical composition and preparation for oral administration
12/13/2012US20120315296 Lentiviral gene transfer vectors and their medicinal applications
12/13/2012US20120315295 Development of a Marker Foot and Mouth Disease Virus Vaccine Candidate That is Attenuated in the Natural Host
12/13/2012US20120315294 Needle-free administration of PRRSV vaccines
12/13/2012US20120315293 Antigen Delivery Vectors and Constructs
12/13/2012US20120315292 Immunogenic compositions for streptococcus pyogenes
12/13/2012US20120315291 Purine derivatives and their pharmaceutical uses
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315278 Human binding molecules having killing activity against enterococci and uses thereof
12/13/2012US20120315277 Compositions and Methods for the Therapy and Diagnosis of Influenza
12/13/2012US20120315270 Rsv immunogens, antibodies and compositions thereof
12/13/2012US20120315269 Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
12/13/2012US20120315266 Detecting complement activation
12/13/2012US20120315265 Hydrogel-forming polymer, and preparation process and uses thereof
12/13/2012US20120315261 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage
12/13/2012US20120315260 Compositions and Methods to Prevent and Treat Biofilms
12/13/2012US20120315249 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
12/13/2012US20120315245 Immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections
12/13/2012US20120315233 Anthranillic acid amides and derivatives thereof as cosmetic and pharmaceutical active compounds
12/13/2012CA2838604A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 1798